Vitamin K Deficiency Diagnosis and Management

Diagnostic Criteria

• The American Academy of Pediatrics recommends that vitamin K deficiency is the most likely cause of umbilical stump bleeding and prolonged aPTT in newborns, particularly if PT is also prolonged 1
• Vitamin K deficiency affects multiple coagulation factors simultaneously because factors II, VII, IX, and X are all vitamin K-dependent 1
• A prolonged PT with normal fibrinogen and platelet count is almost diagnostic of vitamin K deficiency bleeding (VKDB) in a bleeding infant 1

Clinical Presentation

• Umbilical stump bleeding is a classic presentation of vitamin K deficiency in newborns, along with bleeding from circumcision, generalized ecchymoses, and intramuscular hemorrhages 1
• The absence of vitamin K prophylaxis at birth is a significant risk factor for VKDB, and not all states require vitamin K administration 1

Diagnostic Confirmation and Management

• The diagnosis of VKDB is confirmed by rapid correction of PT/aPTT within 30 minutes to 2-4 hours after vitamin K administration, and measurement of proteins induced by vitamin K absence (PIVKA) can confirm the diagnosis in patients already treated with vitamin K or fresh-frozen plasma 1
• The American Academy of Pediatrics recommends administering 1 mg vitamin K intramuscularly or intravenously immediately while awaiting confirmatory laboratory correction, and considering fresh-frozen plasma for immediate factor replacement in life-threatening bleeding 1

Risk Factors and Prevention

• Breast-feeding is a primary risk factor for VKDB, as breast milk contains insufficient vitamin K, and determining if vitamin K prophylaxis was administered at birth is crucial 1
• The American Academy of Pediatrics recommends verifying vitamin K administration at birth, as compliance varies and some institutions/states do not mandate it 1

Vitamin K Deficiency Diagnosis and Management

Laboratory Pattern Analysis

• Prolonged PT and aPTT together indicate deficiency of factors in the common pathway and both extrinsic and intrinsic pathways, which is the hallmark of Vitamin K deficiency affecting factors II, VII, IX, and X 2
• Normal bleeding time excludes platelet dysfunction and von Willebrand disease, as these conditions would prolong bleeding time due to impaired primary hemostasis 3

Differential Diagnosis

• Hemophilia A is excluded because it would prolong only the aPTT, not the PT, since factor VIII is part of the intrinsic pathway only 2
• Von Willebrand disease is excluded because it typically presents with prolonged bleeding time due to impaired platelet adhesion, and the bleeding time is explicitly normal in this case 3

Diagnostic Confirmation and Management

• The diagnosis is confirmed by rapid correction of PT/aPTT within 30 minutes to 2-4 hours after vitamin K administration, although this is not directly cited, the management approach is based on the understanding of Vitamin K deficiency 2
• Immediate treatment consists of vitamin K administration, with expected response of shortened prothrombin time within 2-4 hours, although the specific details of treatment are not directly cited, the importance of prompt treatment is implied by the discussion of diagnosis and management 2

Vitamin K Deficiency Bleeding Diagnosis and Management

Diagnostic Considerations

• The American Academy of Pediatrics recommends considering Vitamin K Deficiency Bleeding (VKDB) in infants with significant bleeding after circumcision, and notes that VKDB must be ruled out first given its treatability and the laboratory pattern, with significant bleeding after circumcision increasing the possibility of a bleeding disorder 4, 5
• Prolongation of PT and PTT can also occur from specimen handling issues or other acquired causes, according to the American Academy of Pediatrics 6

Management and Treatment

• The American Academy of Pediatrics notes that administration of vitamin K can correct coagulopathy within 2-4 hours, and if this does not occur, further evaluation for inherited bleeding disorders should be pursued 4

Vitamin K Deficiency Diagnosis and Management

Diagnostic Criteria

• Measurement of proteins induced by vitamin K absence (PIVKA-II) can provide additional confirmation of vitamin K deficiency bleeding in a bleeding infant, according to the Clinical Nutrition guideline society 7

Diagnostic Confirmation

Management of Vitamin K Deficiency Bleeding in Newborns

Diagnosis and Treatment

• The American Academy of Pediatrics recommends that Fresh Frozen Plasma (FFP) should be reserved for life-threatening bleeding requiring immediate hemostasis while awaiting Vitamin K effect, as FFP provides temporary factor replacement but does not address the underlying Vitamin K deficiency, and carries risks including transfusion-related acute lung injury (TRALI), circulatory overload, and infectious disease transmission 8

Special Considerations

• The presence of hepatomegaly in a newborn with bleeding does not contraindicate Vitamin K administration, and may actually indicate hepatic dysfunction contributing to decreased Vitamin K-dependent factor synthesis, according to the American College of Clinical Pharmacy 8

Management of Newborn with Hepatomegaly and Bleeding

Immediate Treatment and Diagnostic Approach

• The American Academy of Pediatrics recommends administering FFP 10-20 mL/kg for immediate factor replacement in life-threatening bleeding while awaiting vitamin K effect, as stated by the Chest guideline 9
• Platelet transfusion should be considered if platelet count <50 × 10⁹/L with active bleeding, according to the Anaesthesia guideline 10

Critical Decision Points

• If life-threatening bleeding develops, FFP and platelet transfusion may be necessary, with a dosage of 10-20 mL/kg for FFP, as recommended by the Chest guideline 9
• In cases of life-threatening bleeding, the Anaesthesia guideline suggests considering platelet transfusion if platelet count <50 × 10⁹/L with active bleeding 10

Approach to Newborns with Bleeding and Hepatomegaly

Diagnostic Evaluation and Management

• The American Academy of Pediatrics recommends assessing bilirubin levels, including direct and indirect, and transaminases (AST, ALT) to evaluate liver dysfunction in newborns with hepatomegaly and bleeding 11
• In cases of homozygous protein C deficiency, the American College of Chest Physicians recommends treatment with fresh frozen plasma (FFP) 10-20 mL/kg every 12 hours or protein C concentrate 20-60 units/kg until lesions resolve, with a Grade 1A recommendation 11

Rare but Critical Differential Diagnoses

• The presence of purpura fulminans-like skin lesions in a newborn with bleeding and hepatomegaly may indicate homozygous protein C deficiency, requiring immediate hematology consultation and long-term anticoagulation or liver transplantation 11